Zalupski MM - Search Results

1

Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.

Zalupski MM, Benedetti J, Balcerzak SP, Hutchins LF, Belt RJ, Hantel A, Goodwin JW. Zalupski MM, et al. Invest New Drugs. 1993 Nov;11(4):337-41. doi: 10.1007/BF00874435. Invest New Drugs. 1993. PMID: 8157477 Clinical Trial.

2

Reply to "Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?".

Sahai V, Zalupski MM. Sahai V, et al. Among authors: zalupski mm. Cancer. 2023 Apr 1;129(7):1131-1132. doi: 10.1002/cncr.34659. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692955 Free article. No abstract available.

3

Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.

Zalupski M, Metch B, Balcerzak S, Fletcher WS, Chapman R, Bonnet JD, Weiss GR, Ryan J, Benjamin RS, Baker LH. Zalupski M, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):926-32. doi: 10.1093/jnci/83.13.926. J Natl Cancer Inst. 1991. PMID: 2067035 Clinical Trial.

4

Systemic adjuvant chemotherapy for soft tissue sarcomas.

Zalupski MM, Baker LH. Zalupski MM, et al. Hematol Oncol Clin North Am. 1995 Aug;9(4):787-800. Hematol Oncol Clin North Am. 1995. PMID: 7490241 Review.

5

Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma.

Momin FA, Zalupski M, Heilbrun LK, Flaherty L, Fyfe G, Baker LH, Redman BG. Momin FA, et al. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):224-8. doi: 10.1097/00002371-199410000-00007. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834122 Clinical Trial.

6

Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.

Blair SC, Zalupski MM, Baker LH. Blair SC, et al. Among authors: zalupski mm. Am J Clin Oncol. 1994 Dec;17(6):480-4. doi: 10.1097/00000421-199412000-00005. Am J Clin Oncol. 1994. PMID: 7977164 Clinical Trial.

7

Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas.

Zalupski MM, Baker LH. Zalupski MM, et al. J Infus Chemother. 1995 Summer;5(3):129-31. J Infus Chemother. 1995. PMID: 8528970 Clinical Trial.

8

Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor response.

Redman BG, Chou TH, Zalupski M, Uberti J, Flaherty L, Dan M, Sensenbrenner L. Redman BG, et al. J Immunother Emphasis Tumor Immunol. 1995 Aug;18(2):115-8. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8574466 Clinical Trial.

9

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

Foster BJ, LoRusso PM, Poplin E, Zalupski M, Valdivieso M, Wozniak A, Flaherty L, Kasunic DA, Earhart RH, Baker LH. Foster BJ, et al. Invest New Drugs. 1996;13(4):321-6. doi: 10.1007/BF00873138. Invest New Drugs. 1996. PMID: 8824350 Clinical Trial.

10

GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group study.

Hicks LG, Balcerzak SP, Zalupski M. Hicks LG, et al. Cancer Invest. 1996;14(6):507-12. doi: 10.3109/07357909609076895. Cancer Invest. 1996. PMID: 8951354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters